文献・資料をご希望の際は、資料請求ページの備考欄に見出し番号（下記リストの赤色の数字）を入力の上、ご連絡ください。

資料請求はこちら ▶

薬剤性腎障害（Toxicology）関連の文献 一覧 【新着順】

• 201Urinary liver-type fatty acid-binding protein in two dogs with acquired Fanconi syndrome: A case report. Open Vet J.2022
  doi: 10.5455/OVJ.2022.v12.i6.12 PubMed
• 188Urinary L-type fatty acid-binding protein is a predictor of cisplatin-induced acute kidney injury. BMC Nephrol. 2022
  doi: 10.1186/s12882-022-02760-4. PubMed
• 184Clinical Utility of a Biomarker to Detect Contrast-Induced Acute Kidney Injury during Percutaneous Cardiovascular Procedures. Cardiorenal Med. 2022
  doi: 10.1159/000520820. PubMed
• 167Changing trends in lipid profile and biomarkers of renal function and bone metabolism before and after switching from tenofovir disoproxil fumarate to tenofovir alafenamide: a prospective observational study. AIDS Res Ther.2021
  doi: 10.1186/s12981-021-00354-y.PubMed
• 153Early changes in tubular dysfunction markers and phosphorus metabolism regulators as a result of switching from entecavir to tenofovir alafenamide fumarate nucleoside analog therapy for chronic hepatitis B patients. Hepatol Res.2020
  doi: 10.1111/hepr.13451.PubMed
• 145The influence of renal function by ibuprofen treatment for patent ductus arteriosus in extremely low-birth-weight infants.Pediatr Int.2019PubMed
• 140Utility of urinary liver-type fatty acid-binding protein as a predictor of renal dysfunction in Japanese patients with HIV receiving tenofovir disoproxil fumarate with low urinary β2 microglobulin levels: a retrospective observational study.J Pharm Health Care Sci.2019PubMed
• R29Biomarkers of drug-induced kidney toxicity. Ther Drug Monit.2018PubMed
• R27The ischemic/nephrotoxic Acute Kidney Injury and the use of renal biomarkers in clinical practice.Eur J Intern Med.2016PubMed
• R26The potential use of biomarkers in predicting contrast-induced acute kidney injury.Int J Nephrol Renovasc Dis.2016PubMed
• 106Renoprotective effect of the xanthine oxidoreductase inhibitor, Topiroxostat,on Adenine-Induced Renal Injury.Am J Physiol Renal Physiol.310(11):F1366-1376, 2016.PubMed
• 90Response of urinary liver-type fatty acid-binding protein to contrast media administration has a potential to predict one-year renal outcome in patients with ischemic heart disease.Heart Vessels.30(3): 296-303, 2015.PubMed
• 79Human liver-type fatty acid-binding protein protects against tubulointerstitial injury in aldosterone-induced renal injury.Am J Physiol Renal Physiol.308(2): F114-121, 2014.PubMed
• 70Urine liver-type fatty acid-binding protein and kidney injury molecule-1 in HIV-infected patients receiving combined antiretroviral treatment based on tenofovir.AIDS Res Hum Retroviruses.30(4): 363-369, 2014.PubMed
• 64Remote Ischemic Pre-Conditioning Alleviates ContrastInduced Acute Kidney Injury in Patients With Moderate Chronic Kidney Disease.Circulation Journal.77(12): 3037-3044, 2013.PubMed
• 57Urinary liver-type fatty acid-binding protein level as a predictive biomarker of contrast-induced acute kidney injury.Eur J Clin Invest.42(5): 557-563, 2012.PubMed
• 47Renal liver-type fatty acid binding protein (L-FABP) attenuates acute kidney injury in aristolochic acid nephrotoxicity.Am J Pathol.178(3): 1021-1032, 2011.PubMed
• 36Urinary excretion of liver type fatty acid binding protein accurately reflects the degree of tubulointerstitial damage.Am J Pathol.174(6): 2096-2106, 2009.PubMed
• 32Monitoring of urinary L-type fatty acid-binding protein predicts histological severity of acute kidney injury.Am J Pathol.174(4): 1154-1159, 2009.PubMed
• 28Urinary human L-FABP is a potential biomarker to predict COX-inhibitor-induced renal injury.Nephron Exp Nephrol.108(1): e19-26, 2008.PubMed
• 26Renal L-type fatty acid-binding protein mediates the bezafibrate reduction of cisplatin-induced acute kidney injury.Kidney Int.73(12): 1374-1384, 2008.PubMed
• 23L-Type Fatty Acid Binding Protein Transgenic Mouse as a Novel Tool to Explore Cytotoxicity to Renal Proximal Tubules.Drug Metab. Pharmacokinet.23(4): 271-278, 2008.PubMed
• 18A role of liver fatty acid-binding protein in cisplatin-induced acute renal failure.Kidney Int.72(3): 348-358, 2007.PubMed
• 17Urinary excretion of liver-type fatty acid-binding protein in contrast medium-induced nephropathy.Am J Kidney Dis.47(3): 439-444, 2006.PubMed

文献・資料をご希望の際は、資料請求ページの備考欄に見出し番号（下記リストの最初の数字）を入力の上、ご連絡ください。

資料請求はこちら ▶

文献カテゴリー

慢性腎臓病（CKD）　急性腎障害（AKI）　薬剤性腎障害（Toxicology）
薬理学（Pharmacology）　運動（Exercise）　新型コロナウイルス感染症（COVID-19）　日本語総説　ガイドラインなど